Strides Pharma Science Limited — JV/Acquisition, 11-12-2024: Demerger

Strides Pharma Science Limited has undergone a demerger, transferring its identified CDMO and Soft Gelatin businesses into Onesource Specialty Pharma Limited. As part of this arrangement, shareholders of Strides will receive one fully paid-up equity share of Onesource for every two shares held in Strides, determining eligibility as of the record date. The cost of acquisition for shareholders post-demerger is advised to be apportioned, with 89.35% attributed to Strides and 10.65% to Onesource. This strategic move aims to unlock shareholder value and streamline focus on core operations.